Brady W. Dougan - 25 May 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director, 10%+ Owner
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
25 May 2023
Transactions value $
-$7,218,750
Form type
4
Filing time
26 May 2023, 17:04:03 UTC
Previous filing
02 Mar 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$7.22M -2.63M -14.59% $2.75 15.4M 25 May 2023 By Ayabudge LLC F1
holding HUMA Common Stock 510K 25 May 2023 Direct
holding HUMA Common Stock 1.27M 25 May 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.